secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0000950170-23-015323
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma CSO Dr. Trevor Hallam resigns, effective May 31, 2023
---------------------------------------------------------------------

- Dr. Trevor Hallam resigns as President of Research and Chief Scientific Officer effective May 31, 2023.
- Resignation is not due to any disagreement with management or the board.
- No successor has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017023015323/0000950170-23-015323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017023015323/stro-20230424.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-015323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer